 WATERTOWN, Mass., Nov. 10, 2020 GLOBE NEWSWIRE -- Pandion Therapeutics, Inc. Nasdaq: PAND, a clinical-stage biotechnology company developing novel therapeutics designed to address the unmet needs of patients living with autoimmune diseases, today announced that Rahul Kakkar, M.D., Chief Executive Officer of Pandion Therapeutics, will present at the upcoming Stifel 2020 Virtual Healthcare Conference on Tuesday, November 17, 2020 at 4:00 p.m. ET. 